The Latest Headlines at American Banking and Market News
StockNews.com Downgrades Alkermes (NASDAQ:ALKS) to Hold
Alkermes (NASDAQ:ALKS – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Friday. ALKS has been the topic of several other research... More of this article »
Ascendis Pharma A/S (NASDAQ:ASND) PT Raised to $262.00
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) had its price objective upped by equities research analysts at Wells Fargo & Company from $260.00 to $262.00 in a research note issued to investors on Friday, Benzinga... More of this article »
ASLAN Pharmaceuticals (NASDAQ:ASLN) Stock Rating Reaffirmed by HC Wainwright
ASLAN Pharmaceuticals (NASDAQ:ASLN – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research note issued on Friday, Benzinga reports. They presently have... More of this article »
Altair Engineering (NASDAQ:ALTR) Rating Reiterated by Needham & Company LLC
Altair Engineering (NASDAQ:ALTR – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company LLC in a report issued on Friday, Benzinga reports. They currently... More of this article »
USCB Financial Holdings, Inc. (NASDAQ:USCB) Director Purchases $10,062.00 in Stock
USCB Financial Holdings, Inc. (NASDAQ:USCB – Get Free Report) Director Ramon A. Rodriguez acquired 900 shares of the firm’s stock in a transaction on Tuesday, April 30th. The shares were bought at an average cost of $11.18... More of this article »
StockNews.com Lowers ArcBest (NASDAQ:ARCB) to Hold
StockNews.com lowered shares of ArcBest (NASDAQ:ARCB – Free Report) from a buy rating to a hold rating in a research report sent to investors on Thursday morning. A number of other research analysts have also recently weighed... More of this article »
Insider Buying: Waratah Minerals Limited (ASX:WTM) Insider Acquires A$10,125.00 in Stock
Waratah Minerals Limited (ASX:WTM – Get Free Report) insider Andrew Stewart acquired 75,000 shares of the firm’s stock in a transaction on Wednesday, April 24th. The stock was purchased at an average cost of A$0.14 ($0.09)... More of this article »
Ascendis Pharma A/S (NASDAQ:ASND) Stock Rating Reaffirmed by Cantor Fitzgerald
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a research report issued to clients and investors on Friday,... More of this article »
Aditya Kohli Sells 723 Shares of HilleVax, Inc. (NASDAQ:HLVX) Stock
HilleVax, Inc. (NASDAQ:HLVX – Get Free Report) Director Aditya Kohli sold 723 shares of the company’s stock in a transaction that occurred on Friday, May 3rd. The shares were sold at an average price of $14.15, for a total... More of this article »
Orion Group Holdings, Inc. (NYSE:ORN) Director Acquires $10,430.00 in Stock
Orion Group Holdings, Inc. (NYSE:ORN – Get Free Report) Director Quentin P. Jr. Smith acquired 1,400 shares of the stock in a transaction on Thursday, May 2nd. The shares were bought at an average price of $7.45 per share, with... More of this article »
Appian (NASDAQ:APPN) PT Lowered to $32.00
Appian (NASDAQ:APPN – Get Free Report) had its price objective lowered by Barclays from $36.00 to $32.00 in a report issued on Friday, Benzinga reports. The brokerage presently has an “underweight” rating on the... More of this article »
Mark Wellings Sells 15,612 Shares of Li-Cycle Holdings Corp. (NYSE:LICY) Stock
Li-Cycle Holdings Corp. (NYSE:LICY – Get Free Report) Director Mark Wellings sold 15,612 shares of the stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $0.66, for a total transaction of... More of this article »
Ascendis Pharma A/S (NASDAQ:ASND) PT Raised to $170.00 at JPMorgan Chase & Co.
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) had its price objective raised by stock analysts at JPMorgan Chase & Co. from $167.00 to $170.00 in a research report issued on Friday, Benzinga reports. The brokerage... More of this article »